Dating Startups Target Fake Profiles as Verification Technology Gains Traction Portfolio Manager Trims Position After Stock Surges 80 Since April Citing Parabolic Move Caution Gavin Newsoms Office Warns Against Branded Fuel as RipOffBut Studies Suggest Premium Gas May Offer Value US Productivity Growth Slows in Q4 While Labor Costs Accelerate Investors Shift Focus to SmallCap AI Tech Stocks for Potential Growth Opportunities CBS Paramount Retreat from Copyright Dispute After Colbert Parody Goes Viral GPCR Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues American Integrity Insurance Group Inc AII Q1 2026 Earnings Earnings Beat Estimates Amid Stable Underwriting Performance Cerus Corporation CERS Q1 2026 Earnings Narrowing Losses Beat Estimates as Cost Discipline Strengthens LFST Q1 2026 Earnings A Massive EPS Surprise Overshadowed by Market Skepticism RPT Q1 2026 Earnings Significant EPS Miss as Net Loss of 043 per Share Reported JELD Q1 2026 Earnings Significant EPS Miss Sparks Unexpected Stock Rally Stantec Inc STN Edges Higher With Modest Uptick as Sector Eyes Infrastructure Demand BlackRock Income Trust BKT Gains Ground 1056 Tests Key Resistance Zone Ocular Therapeutix OCUL Rises 3 as Investor Sentiment Strengthens Art Technology Acquisition Corp ARTC Holds Steady Near Trust Value Amidst SPAC Sector Caution XPeng Inc XPEV Rises 125 as EV Sector Sentiment Improves SCHMID Group Warrants SHMDW Decline 7 as Selling Pressure Intensifies Key Support Level in Focus STRF Preferred Stock Holds Steady Near 101 Amid Tight Trading Range VivoPower VIVO Surges Over 10 as Momentum Builds Above Key Support SuRo Capital Corp SSSS Slides 13 as Shares Approach Key Support Near 13 Pliant Therapeutics PLRX Faces Selling Pressure Testing Key Support at 115 K2 Capital Acquisition Rights KTWOR Jump 1579 as Speculation Builds Around Potential Merger Completion Expert Warns Against Buy on Dips Strategy as Market Volatility Persists Says HDFC Securities Devarsh Vakil ULCC Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline Vaxcyte PCVX Creeps Higher as Shares Approach Key Resistance Level